We are live on ! Find out more
ATRA icon

Atara Biotherapeutics
ATRA

82 hedge funds and large institutions have $441M invested in Atara Biotherapeutics in 2017 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 30 increasing their positions, 23 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

8,940% more call options, than puts

Call options by funds: $452K | Put options by funds: $5K

30% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 23

22% more capital invested

Capital invested by funds: $360M → $441M (+$80.8M)

0.06% less ownership

Funds ownership: 3.54% → 3.48% (-0.06%)

2% less funds holding

Funds holding: 84 → 82 (-2)

20% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 10

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
82
Holders Change
-2
Holders Change %
-2.38%
% of All Funds
2.04%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
8
Increased
30
Reduced
23
Closed
10
Calls
$452K
Puts
$5K
Net Calls
+$447K
Net Calls Change
-$158K

Top Buyers

Rank Fund Capital Flow
1
ACH
ArrowMark Colorado Holdings
Colorado
+$10.4M
2
Morgan Stanley
Morgan Stanley
New York
+$6.8M
3
RG
Redmile Group
California
+$2.35M
4
Neuberger Berman Group
Neuberger Berman Group
New York
+$2.22M
5
BM
Bridger Management
New York
+$1.93M

Top Sellers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
-$7.79M
2
GTC
Ghost Tree Capital
New York
-$4.9M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.56M
4
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$829K
5
Citadel Advisors
Citadel Advisors
Florida
-$510K
Name Holding Trade Value Shares
Change 		Change in
Stake
TA
26
Teachers Advisors
New York
$782K +$1.13K +3 +0.2%
IA
27
IndexIQ Advisors
New York
$698K +$288K +765 +83%
California State Teachers Retirement System (CalSTRS)
28
California State Teachers Retirement System (CalSTRS)
California
$667K -$72K -191 -11%
AIMCA
29
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$651K – – –
PA
30
Perceptive Advisors
New York
$581K +$529K +1,404 New
RhumbLine Advisers
31
RhumbLine Advisers
Massachusetts
$523K +$3.39K +9 +0.7%
PPA
32
Parametric Portfolio Associates
Washington
$512K +$19.2K +51 +4%
AA
33
ALPS Advisors
Colorado
$498K +$57.7K +153 +15%
Swiss National Bank
34
Swiss National Bank
Switzerland
$473K – – –
TAM
35
Tiverton Asset Management
Delaware
$466K -$52K -138 -11%
AllianceBernstein
36
AllianceBernstein
Tennessee
$459K – – –
EIM
37
Essex Investment Management
Massachusetts
$429K +$390K +1,036 New
CS
38
Credit Suisse
Switzerland
$423K +$185K +490 +92%
Deutsche Bank
39
Deutsche Bank
Germany
$421K -$73.1K -194 -16%
New York State Common Retirement Fund
40
New York State Common Retirement Fund
New York
$409K – – –
RJA
41
Raymond James & Associates
Florida
$391K – – –
Dimensional Fund Advisors
42
Dimensional Fund Advisors
Texas
$377K +$15.8K +42 +5%
Millennium Management
43
Millennium Management
New York
$359K +$328K +869 New
OWIM
44
Old West Investment Management
California
$345K -$27.1K -72 -8%
Manulife (Manufacturers Life Insurance)
45
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$337K -$1.13K -3 -0.4%
Goldman Sachs
46
Goldman Sachs
New York
$330K +$81K +215 +37%
ProShare Advisors
47
ProShare Advisors
Maryland
$314K +$26.8K +71 +10%
Invesco
48
Invesco
Georgia
$311K +$13.6K +36 +5%
State of Wisconsin Investment Board
49
State of Wisconsin Investment Board
Wisconsin
$298K – – –
MLICM
50
Metropolitan Life Insurance Company (MetLife)
New York
$293K – – –
1
2
3 4

ATRA Hedge Fund Activity: Q3 2017 in Review

82 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Atara Biotherapeutics (ATRA) for Q3 2017, worth a combined $441M — up 22% from $360M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of ATRA and 8 opened new positions — a net loss of 2 holders — while 23 trimmed existing stakes and 30 added.

The largest buyer was ArrowMark Colorado Holdings, adding an estimated $10.4M. The largest seller was RTW Investments, cutting an estimated $7.79M.

  • 82 institutional investors held Atara Biotherapeutics (ATRA) as of Q3 2017, down from 84 in Q2 2017.
  • Funds reported $441M of Atara Biotherapeutics stock for Q3 2017, up 22% quarter-over-quarter.
  • 8 funds opened new Atara Biotherapeutics positions in Q3 2017 and 10 closed out, a net change of -2 holders.
  • The largest Atara Biotherapeutics buyer in Q3 2017 was ArrowMark Colorado Holdings, an estimated $10.4M added.
  • The largest Atara Biotherapeutics seller in Q3 2017 was RTW Investments, an estimated $7.79M sold.

Based on aggregated 13F filings for Q3 2017.